PROBUCOL - COMPARISON WITH PLACEBO IN TYPE-II HYPERLIPOPROTEINEMIA

被引:0
作者
BEAUMONT, V
机构
来源
NOUVELLE PRESSE MEDICALE | 1980年 / 9卷 / 40期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:3011 / 3013
页数:3
相关论文
共 18 条
[1]  
[Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360
[2]  
Beaumont J L, 1975, Triangle, V14, P9
[3]  
BEAUMONT JL, 1980, NOUV PRESSE MED, V9, P2995
[4]  
BEAUMONT V, 1979, MED HYG, V37, P3653
[5]  
BEUMONT JL, 1970, B WORLD HEALTH ORGAN, V43, P891
[6]  
BROWN HB, 1974, CLIN PHARMACOL THER, V16, P44
[7]  
CANOSA FL, 1974, 5TH INT S DRUGS AFF, P36
[8]  
DAVIGNON J, 1974, 3RD INT S ATH, P794
[9]  
ETIENNE G, 1963, ANN BIOL CLIN, V21, P851
[10]   LONG-TERM ORAL-ADMINISTRATION OF PROBUCOL [4,4'-(ISOPROPYLIDENEDITHIO)BIS (2,6-DI-T-BUTYLPHENOL)] (DH-581) IN MANAGEMENT OF HYPERCHOLESTEROLEMIA [J].
HARRIS, RS ;
GILMORE, HR ;
BRICKER, LA ;
KIEM, IM ;
RUBIN, E .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1974, 22 (04) :167-175